CDKs as cancer target CDK inhibitor






^ malumbres, m; barbacid, m (2001). cycle or not cycle: critical decision in cancer . nature reviews cancer. 1 (3): 222–31. doi:10.1038/35106065. pmid 11902577. 
^ malumbres, m; barbacid, m (2009). cell cycle, cdks , cancer: changing paradigm . nature reviews cancer. 9 (3): 153–66. doi:10.1038/nrc2602. pmid 19238148. 
^ barrière, c; santamaría, d; cerqueira, a; galán, j; martín, a; ortega, s; malumbres, m; dubus, p; barbacid, m (2007). mice thrive without cdk4 , cdk2 . molecular oncology. 1 (1): 72–83. doi:10.1016/j.molonc.2007.03.001. pmid 19383288. 
^ malumbres, m; pevarello, p; barbacid, m; bischoff, j. r. (2008). cdk inhibitors in cancer therapy: next? . trends in pharmacological sciences. 29 (1): 16–21. doi:10.1016/j.tips.2007.10.012. pmid 18054800. 






Comments

Popular posts from this blog

CEFR alignment Euroexam International

File format Wavefront .obj file

Books Soma Valliappan